Search | Page 9 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

    ... Leukemias/lymphomas Acute myeloid leukemia, primary or secondary Disease status: remission or <10% ... Disease status: in hematologic remission Chronic myelogenous leukemia Disease status: chronic phase, accelerated phase or blast ...

    Clinical Trial last updated 06/03/2016 - 2:45pm.

  2. Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

    ... Patients must have one of the following disease types: Acute myeloid leukemia (AML) with disease features as described in the ... disease features as described in the protocol. Chronic myelogenous leukemia (CML) with disease features as described in the protocol. ...

    Clinical Trial last updated 06/06/2016 - 3:37pm.

  3. Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease

    ... is expected. This includes, but is not limited to: Acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) in first complete remission Chronic myelogenous leukemia (CML) in chronic phase with tyrosine kinase inhibitor ...

    Clinical Trial last updated 06/06/2016 - 3:04pm.

  4. Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

    ... Patients must have one of the following disease types: Acute myeloid leukemia (AML) with disease features as described in the ... disease features as described in the protocol. Chronic myelogenous leukemia (CML) with disease features as described in the protocol. ...

    Clinical Trial last updated 06/03/2016 - 2:54pm.

  5. Chemotherapy

    ... risk IPSS score, you have a higher risk of developing Acute Myelogenous Leukemia (AML). To prevent this from happening, your doctor may ...

    Page last updated 01/20/2015 - 4:45pm.

  6. MDS - Treatment (OLD)

    ... The risk of developing Acute Myelogenous Leukemia (AML) depends on the type of MDS you have. As a ...

    Topic section last updated 03/10/2016 - 11:01pm.

  7. Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes

    ... cord blood progenitor cells works in treating patients with acute myeloid leukemia, acute lymphoblastic leukemia, chronic myelogenous leukemia, or myelodysplastic syndromes. Giving chemotherapy ...

    Clinical Trial last updated 04/27/2016 - 1:17pm.

  8. Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant

    ... composed of 2 UCB units. Disease Criteria: Acute Leukemias: Acute myeloid leukemia: high risk complete remission 1 ... CR Natural Killer cell malignancies Chronic myelogenous leukemia: all types except refractory blast crisis. Chronic ...

    Clinical Trial last updated 05/02/2016 - 2:13pm.

  9. Phase I/II MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell

    ... in pre-defined doses and ratios will reduce the incidence of acute graft vs host disease while augmenting the graft vs leukemia effect and ... karyotype with FLT3-ITD mutation Chronic myelogenous leukemia (accelerated, blast or second chronic phase) ...

    Clinical Trial last updated 05/09/2016 - 3:58pm.

  10. Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies

    ... Inclusion Criteria:  Acute lymphoblastic leukemia Acue myelogenous leukemia Myelodysplastic syndrome Non-Hodgkin lymphoma ...

    Clinical Trial last updated 04/29/2016 - 10:59am.